Institute of Clinical and Molecular Virology

SARS-CoV-2 variants with NSP12 P323L/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility (2023) Kim SM, Kim EH, Casel MAB, Kim YI, Sun R, Kwak MJ, Yoo JS, et al. Journal article Re-Analysis of the Widely Used Recombinant Murine Cytomegalovirus MCMV-m157luc Derived from the Bacmid pSM3fr Confirms Its Hybrid Nature (2023) Cordsmeier A, Bednar C, Kübel S, Bauer L, Enßer A Journal article Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study (2023) Werner F, Zeschick N, Kühlein T, Steininger P, Überla K, Kaiser I, Sebastião M, et al. Journal article A Genetically Encoded Dark-to-Bright Biosensor for Visualisation of Granzyme-Mediated Cytotoxicity (2023) Bednar C, Kübel S, Cordsmeier A, Scholz B, Menschikowski H, Enßer A Journal article Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease: Btn2a2 promotes central tolerance (2023) Frech M, Danzer H, Uchil P, Azizov V, Schmid E, Schälter F, Dürholz K, et al. Journal article Autofluorescent Artemisinin-Benzimidazole Hybrids via Organo-Click Reaction: Study of Antiviral Properties and Mode of Action in Living Cells (2023) Herrmann L, Hahn F, Grau B, Wild M, Niesar A, Wangen C, Kataev E, et al. Journal article Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators (2023) Schmitt V, Masanetz RK, Weidenfeller M, Ebbinghaus LS, Süß P, Rosshart SP, von Hörsten S, et al. Journal article XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors (2023) Heger L, Hatscher L, Liang C, Lehmann C, Amon L, Lühr JJ, Kaszubowski T, et al. Journal article Alcohol-sourced acetate impairs T cell function by promoting cortactin acetylation (2023) Azizov V, Hübner M, Frech M, Hofmann J, Kubankova M, Lapuente D, Tenbusch M, et al. Journal article SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies (2023) Reuter N, CHEN X, Kropff B, Peter AS, Britt WJ, Mach M, Überla K, Thomas M Journal article